Last update 01 Nov 2024
Patheon Manufacturing Services LLC
Subsidiary Company|
North Carolina, United States
Last update 01 Nov 2024
Overview
Related
一项在系统性红斑狼疮成人受试者中评价MK-6194有效性和安全性的IIa期、多中心、随机、双盲、安慰剂对照研究。
[Translation] A Phase IIa, multicenter, randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of MK-6194 in adult subjects with systemic lupus erythematosus.
一项在不适合或不计划接受自体干细胞移植作为初始治疗的新诊断多发性骨髓瘤受试者中比较Teclistamab联合达雷妥尤单抗皮下（SC）和来那度胺（Tec-DR）以及Talquetamab联合达雷妥尤单抗SC和来那度胺（Tal-DR）与达雷妥尤单抗SC、来那度胺和地塞米松（DRd）的III期、随机研究
[Translation] A Phase III, Randomized Study Comparing Teclistamab in Combination with Daratumumab Subcutaneously (SC) and Lenalidomide (Tec-DR) and Talquetamab in Combination with Daratumumab SC and Lenalidomide (Tal-DR) versus Daratumumab SC, Lenalidomide, and Dexamethasone (DRd) in Subjects with Newly Diagnosed Multiple Myeloma Who Are Not Eligible for or Not Planned to Undergo Autologous Stem Cell Transplantation as Initial Therapy
一项在接受过1线-4线治疗（包括一种抗CD38抗体和来那度胺治疗）的复发性或难治性多发性骨髓瘤受试者中比较Talquetamab联合泊马度胺（Tal-P）、Talquetamab联合Teclistamab（Tal-Tec）和研究者选择的Elotuzumab、泊马度胺和地塞米松（EPd）或泊马度胺、硼替佐米和地塞米松（PVd）的III期随机研究
[Translation] A Phase III, randomized study comparing talquetamab plus pomalidomide (Tal-P), talquetamab plus teclistamab (Tal-Tec), and investigator's choice of elotuzumab, pomalidomide, and dexamethasone (EPd) or pomalidomide, bortezomib, and dexamethasone (PVd) in subjects with relapsed or refractory multiple myeloma who have received 1 to 4 lines of therapy, including an anti-CD38 antibody and lenalidomide
100 Clinical Results associated with Patheon Manufacturing Services LLC
Login to view more data
Login to view more data
100 Deals associated with Patheon Manufacturing Services LLC
Login to view more data
100 Translational Medicine associated with Patheon Manufacturing Services LLC
Login to view more data
Corporation Tree
Boost your research with our corporation tree data.
login
or
Pipeline
Pipeline Snapshot as of 23 Nov 2024
No data posted
Login to keep update
Deal
Boost your decision using our deal data.
login
or
Translational Medicine
Boost your research with our translational medicine data.
login
or
Profit
Explore the financial positions of over 360K organizations with Synapse.
login
or
Grant & Funding(NIH)
Access more than 2 million grant and funding information to elevate your research journey.
login
or
Investment
Gain insights on the latest company investments from start-ups to established corporations.
login
or
Financing
Unearth financing trends to validate and advance investment opportunities.
login
or
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free